What Makes A "Successful" Kasai Portoenterostomy "Unsuccessful"?
- PMID: 36574004
- DOI: 10.1097/MPG.0000000000003638
What Makes A "Successful" Kasai Portoenterostomy "Unsuccessful"?
Abstract
Objectives: Clearance of jaundice (CoJ) is the first key objective of Kasai portoenterostomy (KPE) for biliary atresia (BA) and its achievement is by far the best index of long-term prognosis. We sought to identify the reasons for failure [subsequent liver transplant (LT)] in this cohort.
Methods: Review of single-center prospective BA database. Successful KPE was defined by achieving a postoperative bilirubin of ≤20 µmol/L. Pre-KPE and post-KPE variables were identified together with a multivariate logistic regression model to identify those observable at 3 months post-KPE. Data are quoted as median (range). A P value of ≤0.05 was significant.
Results: One hundred thirty-five infants underwent KPE between January 2012 and December 2018, of which 90 (67%) achieved CoJ. From these 20 (22%) (Cohort A) underwent LT with the remainder continuing with native liver (Cohort B) (median follow-up of 4.15 years). There was no difference in age at KPE ( P = 0.41), APRi (aspartate aminotransferase-to-platelet ratio) ( P = 0.07), associated anomalies ( P = 0.7), and cytomegalovirus status ( P = 0.7) between the 2 groups. Postoperatively, both cholangitis [any episode, 18/20 (90%) vs 15/70 (21%); P < 0.0001] and portal hypertension (PHT) [gastrointestinal (GI) bleed, 10/20 (50%) vs 2/70 (2.8%); P < 0.0001] were significantly more common in cohort A. Univariate analysis showed that the most significant predictive values at 3 months for LT by 2 years were high APRi, bilirubin, international normalized ratio, and ultrasound (US)-detected ascites with multivariate logistic modeling confirming these variables with predictive values of r2 = 0.79, AUROC = 0.98.
Conclusions: Failure is not preordained at KPE but due to recurrent cholangitis and/or symptoms of PHT.
Copyright © 2022 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Response to Letter RE: What Makes A "Successful" Kasai Portoenterostomy "Unsuccessful?".J Pediatr Gastroenterol Nutr. 2023 Nov 1;77(5):e70-e71. doi: 10.1097/MPG.0000000000003881. Epub 2023 Jul 7. J Pediatr Gastroenterol Nutr. 2023. PMID: 37417831 No abstract available.
-
Appropriate Treatment of Cholangitis Can Prevent Successful Kasai Portoenterostomy Progressing to Liver Transplantation.J Pediatr Gastroenterol Nutr. 2023 Nov 1;77(5):e70. doi: 10.1097/MPG.0000000000003880. Epub 2023 Jul 7. J Pediatr Gastroenterol Nutr. 2023. PMID: 37417867 No abstract available.
References
-
- Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374:1704–13.
-
- Tan CE, Davenport M, Driver M, Howard ER. Does the morphology of the extrahepatic biliary remnants in biliary atresia influence survival? A review of 205 cases. J Pediatr Surg. 1994;29:1459–64.
-
- Davenport M, De Ville de Goyet J, Stringer MD, et al. Seamless management of biliary atresia in England and Wales (1999–2002). Lancet. 2004;363:1354–7.
-
- Davenport M, Ong E, Sharif K, et al. Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg. 2011;46:1689–94.
-
- Koga H, Wada M, Nakamura H, et al. Factors influencing jaundice-free survival with the native liver in post-portoenterostomy biliary atresia patients: results from a single institution. J Pediatr Surg. 2013;48:2368–72.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
